Research Analysts’ Downgrades for December 19th (ADVM, AI, ALXO, BRLT, CABA, CBSH, CSGS, DAO, EGY, EWCZ)

Research Analysts’ downgrades for Thursday, December 19th:

Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

C3.ai (NYSE:AI) was downgraded by analysts at KeyCorp from a sector weight rating to an underweight rating. The firm currently has $29.00 target price on the stock.

ALX Oncology (NASDAQ:ALXO) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating. Jefferies Financial Group Inc. currently has $2.00 target price on the stock, down from their previous target price of $12.00.

Brilliant Earth Group (NASDAQ:BRLT) was downgraded by analysts at Telsey Advisory Group from an outperform rating to a market perform rating. They currently have $2.00 price target on the stock, down from their previous price target of $3.00.

Cabaletta Bio (NASDAQ:CABA) was downgraded by analysts at Wells Fargo & Company from an overweight rating to an equal weight rating. The firm currently has $6.00 target price on the stock, down from their previous target price of $12.00.

Commerce Bancshares (NASDAQ:CBSH) was downgraded by analysts at Raymond James from an outperform rating to a market perform rating.

CSG Systems International (NASDAQ:CSGS) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.

Youdao (NYSE:DAO) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating.

VAALCO Energy (NYSE:EGY) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

European Wax Center (NASDAQ:EWCZ) was downgraded by analysts at Telsey Advisory Group from an outperform rating to a market perform rating. They currently have $6.00 target price on the stock, down from their previous target price of $8.00.

General Dynamics (NYSE:GD) was downgraded by analysts at Royal Bank of Canada from an outperform rating to a sector perform rating. The firm currently has $290.00 price target on the stock, down from their previous price target of $330.00.

Monte Rosa Therapeutics (NASDAQ:GLUE) was downgraded by analysts at Wells Fargo & Company from an overweight rating to an equal weight rating. Wells Fargo & Company currently has $11.00 target price on the stock, down from their previous target price of $14.00.

Heron Therapeutics (NASDAQ:HRTX) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Hilltop (NYSE:HTH) was downgraded by analysts at Raymond James from a market perform rating to an underperform rating.

Imperial Oil (NYSEAMERICAN:IMO) (TSE:IMO) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating.

Pediatrix Medical Group (NYSE:MD) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.

Micron Technology (NASDAQ:MU) was downgraded by analysts at Bank of America Co. from a buy rating to a neutral rating. Bank of America Co. currently has $110.00 target price on the stock, down from their previous target price of $125.00.

Dr. Reddy’s Laboratories (NYSE:RDY) was downgraded by analysts at Nomura from a buy rating to a neutral rating.

RGC Resources (NASDAQ:RGCO) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Bancorp (NASDAQ:TBBK) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.

Western Digital (NASDAQ:WDC) was downgraded by analysts at Benchmark Co. from a buy rating to a hold rating. Benchmark Co. currently has $70.00 target price on the stock.